.
Angewandte
Communications
Figure 1. Investigation of the priming of the iterative module (AurA). A) The ligase AurE solely plays a role in activating the p-nitrobenzoate
(PNBA) starter unit. For iteration, KS1 must control the rates of priming and retrotransfer of the diketide. B) Aureothin biosynthesis is functional
in the absence of the N-terminus of AurA, and a DaurE mutant can be complemented by a synthetic SNAC derivative. C) Metabolic profiles of
a) S. lividans ZX1:pNT38 (DaurE mutant), b) DaurE mutant supplemented with PNBA, c) DaurE mutant supplemented with PNBA-SNAC,
d) DaurE mutant complemented with aurE (expression plasmid).
same time, the chain initiating PKS module that selects the p-
nitrobenzoate starter unit.[16,17] A prerequisite for the iterative
use of the first module is that the thiol group of the KS1
domain remains vacant. Otherwise, an occupied active site of
the KS domain loaded with the starter unit would hamper the
second elongation step. In consequence, the reconveyance of
the diketide intermediate must proceed faster than the
priming of the first module (Figure 1). For this reason, we
first investigated the loading of the aur PKS with the starter
unit. Because the aur PKS lacks a designated loading module,
we focused on the N-terminal part of the first module AurA
and the acyl-CoA ligase AurE, an enzyme that often assists in
loading a starter unit onto the PKS assembly line.[18] A mutant
lacking the gene for the acyl-CoA ligase was created by
excision of aurE from the aur gene cluster. Interestingly,
aureothin production was completely abolished in this DaurE
mutant. Genetic complementation fully restored aureothin
production, thus excluding any polar effects of the mutant.
Notably, we could also chemically restore aureothin biosyn-
thesis in the aurE mutant when adding the CoA surrogate, the
N-acetyl cysteamine thioester (SNAC) of p-nitro benzoic
acid.[19] This result clearly showed that AurE is solely involved
in starter unit activation, but does not participate in PKS
priming. To rule out the involvement of the N-terminal part of
AurA, we also tested the truncated mutant and found that the
N-terminus of AurA is not essential for priming the aureothin
PKS. These findings implied that the KS alone has full control
over priming and chain elongation events.
Next, we investigated the impact of the KS domains on the
iteration process. To exchange the KS1, two single restriction
sites flanking the gene region coding for the AT domain were
introduced in aurA. Using this construct, the gene region for
the KS1 was exchanged by the gene region coding for the
loading module and the KS1 domain of the avermectin
synthase (AVES1).[20–22] The newly generated hybrid module
was introduced into a mutant lacking wild-type aurA. HPLC-
MS analysis of the metabolic profile of the recombinant strain
revealed the formation of a new compound.
The metabolite of the ave/aur hybrid PKS, named
averpyrone, was isolated from large-scale fermentation
broth, and its structure was fully elucidated by HRMS, IR,
and both 1D and 2D NMR spectroscopy. For carbons 2–10,
the NMR data for averpyrone were quite similar to the ones
for deoxyaureothin. C11 (d 46.0) has a distinct chemical shift
compared to C11 (d 139.3) in deoxyaureothin,[23] thus
indicating a carbonyl next to this position. This is supported
by the coupling of H11 (d 3.34) as a quartet of doublets with
H11a and H10. No coupling with other protons could be
1
observed in the H NMR spectrum of H13 (d 2.05), which
suggests a connection to a quaternary carbon. The chemical
shift of C12 (d 203.1) is shifted to lower field. The HMBC
coupling of H11, H11a, and H13 with C12, along with the
deduced molecular composition, established the keto group
in position C12. Whereas averpyrone has been regioselec-
tively methylated by AurI,[24] it lacks the oxygen heterocycle
of aureothin. Apparently, 2 is not the correct substrate of the
multifunctional P-450 monooxygenase AurH, which usually
catalyzes hydroxylation–heterocyclization at C7/C9a.[23,25] As
it has been shown that AurH may install carbonyl groups into
non-natural substrates,[26–28] it is possible that it also intro-
duced the oxo group at C12 (Scheme 2).
Averpyrone features a 2-methylbutyryl side chain in lieu
of the p-nitrophenyl residue. To unequivocally prove the
origin of this moiety, 13C6-l-isoleucine was added to the
engineered hybrid PKS strain. MS analyses revealed a mass
shift of 5 Da that clearly showed the intact incorporation of
a 2-methylbutyrate unit that originates from l-isoleucine by
means of the branched chain alpha-keto acid dehydrogenase
complex (BCKD).[18] The structure of 2 and the labeling
experiments imply that 2-methylbutyl-CoA, which is loaded
onto the ave/aur hybrid PKS, undergoes only four rounds of
elongation. In the hybrid synthase, the number of modules
and the number of elongation steps are in perfect agreement
with the rule of colinearity. Clearly the first module had lost
its ability to catalyze two rounds of elongations. Conse-
quently, the genuine KS1 domain of AurA plays a crucial role
in the iteration event. The successful production of averpyr-
one has yet another implication. The size of its backbone and
the methyl branching pattern of the biosynthetic intermediate
produced by the hybrid module resemble the intermediate
produced by AurA. The (E)-2-methylpent-2-enoyl moiety is
accepted as a substrate by KS2 and all other downstream PKS
domains. We thus tested a range of alternative starter units
that are usually loaded onto the ave PKS, however, only the
branched building block was incorporated (data not shown).
It appears that the KS has specificity for substrates with
2
ꢀ 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Angew. Chem. Int. Ed. 2013, 52, 1 – 6
These are not the final page numbers!